Related Experiment Videos
Alpha-fetoprotein-producing renal cell carcinoma.
V Poulakis1, U Witzsch, R de Vries
1Department of Urology and Pediatric Urology, Hospital Nordwest, Academic Hospital of the Johann Wolfgang Goethe University of Frankfurt am Main, Frankfurt am Main, Germany. Poulakis@em.uni-frankfurt.de
Urologia Internationalis
|August 8, 2001
Summary
Alpha-fetoprotein (AFP) is rarely produced by renal cell carcinoma (RCC). This case and review suggest AFP may be a more universal marker than previously thought, even in mesoderm-originating tumors.
Area of Science:
- Oncology
- Biochemistry
Background:
- Alpha-fetoprotein (AFP) is a well-established tumor marker for yolk sac tumors and hepatocellular carcinoma.
- Renal cell carcinoma (RCC) is typically not associated with AFP production.
Observation:
- A rare case of AFP-producing RCC with solitary bone metastasis, but no liver involvement, is presented.
- Immunohistochemical staining confirmed AFP presence in the cytoplasm of renal tumor cells.
Findings:
- The review of published cases indicates that mesoderm-originating malignant tumors, including RCC, can produce AFP.
- This suggests AFP may have broader utility as a tumor marker than commonly recognized.
Implications:
- AFP's potential role as a marker in a wider range of cancers, including rare RCC presentations, warrants further investigation.
- This finding could impact diagnostic strategies and understanding of tumor marker expression in oncology.